Source:http://linkedlifedata.com/resource/pubmed/id/18442934
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2008-6-2
|
pubmed:abstractText |
ErbB2, which is a member of the epidermal growth factor (erbB) receptor family, is frequently overexpressed in breast and ovarian cancers. Antibody and small molecule anti-tyrosine kinase inhibitors have been developed for targeted therapies for cancers overexpressing erbB2. Internalization and downregulation of erbB2, which is induced by a ligand, may be important for efficacious therapeutic effects. However, ligand-dependent erbB2 internalization has not been well characterized. Here we investigated the internalization of erbB2 in SKBr3 and SKOv3 cells, both overexpressing erbB2, using an EC-1 peptide fused to eGFP (EC-eGFP), which specifically binds to erbB2. ErbB2 was internalized in SKOv3 cells when the cells were treated with EC-eGFP. The accumulation of endosomal erbB2 was EC-eGFP dependent, which colocalized with transferrin implying endocytosis via clathrin-coated pits. In contrast, internalization of erbB2 was not observed in SKBr3 cells. As a result, two different mechanisms, which are cell type dependent for the internalization of erbB2, are proposed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transferrin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1065-6995
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
814-26
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18442934-Breast Neoplasms,
pubmed-meshheading:18442934-Carcinoma,
pubmed-meshheading:18442934-Cell Line, Tumor,
pubmed-meshheading:18442934-Clathrin-Coated Vesicles,
pubmed-meshheading:18442934-Endocytosis,
pubmed-meshheading:18442934-Humans,
pubmed-meshheading:18442934-Ligands,
pubmed-meshheading:18442934-Peptides, Cyclic,
pubmed-meshheading:18442934-Receptor, erbB-2,
pubmed-meshheading:18442934-Recombinant Fusion Proteins,
pubmed-meshheading:18442934-Transferrin
|
pubmed:year |
2008
|
pubmed:articleTitle |
Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2.
|
pubmed:affiliation |
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-Naka, Okayama 700-8530, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|